Breast Cancer

Cancer burden among older adults with type 2 diabetes has increased in the past 2 decades while all-cause mortality rates at all ages have decreased, according to a 20-year population-based study published in Diabetologia.

Black women who smoked at the time of breast cancer diagnosis had a 52% increased risk for all-cause mortality compared with Black women who never smoked, according to study results published in JAMA Network Open.

Since 2008, the rate of bilateral mastectomy among patients with early-stage breast cancer increased, decreased and finally stabilized with similar rates in 2020 as 2008, according to data published in JAMA Network Open.

Race and geographic location appeared significantly associated with increased risk for treatment delays among women with breast cancer in North Carolina, according to results of a retrospective study published in Cancer.

Female breast cancer survivors had a 60% lower risk for death if they engaged in active or moderate physical activity vs. insufficient activity, according to results of a study published in JAMA Network Open.

Women with early-stage breast cancer who achieve pathologic complete response with neoadjuvant systemic chemotherapy may safely omit surgery with a low likelihood of disease recurrence, according to phase 2 study results.

Follow-up results from the ATEMPT trial showed that trastuzumab emtansine remained effective years after treatment in a subset of breast cancer patients, according to data presented at San Antonio Breast Cancer Symposium.

Among women eligible for Denmark’s national breast cancer screening program, those who had an intellectual disability were less likely to undergo recommended screening, according to findings published in JAMA Network Open.

Among patients with breast cancer in China, those who underwent adjuvant endocrine therapy had more prevalent and more severe menopausal symptoms, according to data published in Menopause.

Despite being the second most prevalent histologic subtype of invasive breast cancer in the U.S., invasive lobular carcinoma is often detected later and yields worse outcomes than invasive ductal carcinoma, the most common invasive subtype.